US Stock MarketDetailed Quotes
PBYI Puma Biotechnology
- 2.900
- +0.060+2.11%
Close Nov 21 16:00 ET
142.35MMarket Cap6.17P/E (TTM)
2.985High2.792Low404.80KVolume2.880Open2.840Pre Close1.18MTurnover1.23%Turnover Ratio6.44P/E (Static)49.09MShares7.73052wk High2.00P/B95.09MFloat Cap2.22552wk Low--Dividend TTM32.79MShs Float279.370Historical High--Div YieldTTM6.80%Amplitude1.600Historical Low2.915Avg Price1Lot Size
About Puma Biotechnology Company
Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.
Company Profile
SymbolPBYI
Company NamePuma Biotechnology
Listing DateMar 21, 2012
Founded2010
CEOMr. Alan H. Auerbach
MarketNASDAQ
Employees185
Fiscal Year Ends12-31
Address10880 Wilshire Boulevard,Suite 2150
CityLos Angeles
ProvinceCalifornia
CountryUnited States of America
Zip Code90024-4101
Phone1-424-248-6500
Company Executives
- Name
- Position
- Salary
- Alan H. Auerbach
- Chairman of the Board, President, Chief Executive Officer and Secretary
- 2.94M
- Douglas M. Hunt
- Chief Regulatory Affairs, Medical Affairs, Pharmacovigilance, and Law Officer
- 1.02M
- Dr. Alvin F. Wong, Pharm.D.
- Chief Scientific Officer
- 1.23M
- Maximo F. Nougues
- Chief Financial Officer and Principal Accounting Officer
- 1.23M
- Jeffrey Jerome Ludwig
- Chief Commercial Officer
- 1.38M
- Dr. Troy E. Wilson, PhD, J.D.
- Independent Director
- 172.27K
- Dr. Alessandra Cesano, M.D.
- Independent Director
- 152.27K
- Michael Patrick Miller
- Independent Director
- 162.90K
- Jay M. Moyes
- Lead Independent Director
- 172.27K
- Brian M. Stuglik, R.Ph.
- Independent Director
- 161.65K
- Allison Dorval
- Independent Director
- 154.77K
- Dr. Adrian Senderowicz, M.D.
- Independent Director
- 164.77K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data